Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
cancer
life sciences
3
×
national
national blog main
bristol-myers squibb
cancer immunotherapy
novartis
samit hirawat
bill &
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
democrats
detroit blog main
detroit top stories
donald trump
drug price
h.r. 3
house
hr 3
indiana blog main
indiana top stories
insulin
insurance
legislation
lower
medicaid
medicare
nancy pelosi
national top stories
negotiation
new york blog main
new york top stories
part b
part d
prescription
president
pricing
What
year
3
×
acquisition
anniversary
approaches
bn
bristol
celgene
chief
clinical
company’s
corporation
diversity
hirawat
medical
myers
myers’s
officer
pipeline
progress
scrip
spoke
squibb
trial
answer
away
democratic
dems
discontent
drugs
election
high
house
nancy
negotiation
party's
pelosi
plan
price
public
speaker
Language
unset
3
×
Current search:
biotech
×
year
×
unset
×
" life sciences "
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?